YUNGJIN PHARM. CO. LTD (003520) Price & Analysis

― Followers

003520 Stock Chart & Stats

₩1211.00

-₩45.00(-3.58%)

Aug 19, 2026

―

Day’s Range― - ―

52-Week Range₩1,081.00 - ₩2,320.00

Previous CloseN/A

VolumeN/A

Average Volume (3M)287.57K

Market Cap

₩229.71B

Enterprise Value₩291.12K

Total Cash (Recent Filing)₩3.59B

Total Debt (Recent Filing)₩77.24B

Price to Earnings (P/E)―

Beta0.18

Next Earnings

Nov 18, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-33.82

Shares Outstanding182,892,730

10 Day Avg. Volume215,929

30 Day Avg. Volume287,569

Financial Highlights & Ratios

PEG Ratio13.62

Price to Book (P/B)4.25

Price to Sales (P/S)1.53

P/FCF Ratio-413.90

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

003520 FAQ

What was YUNGJIN PHARM. CO. LTD’s price range in the past 12 months?

YUNGJIN PHARM. CO. LTD lowest stock price was ₩1081.00 and its highest was ₩2320.00 in the past 12 months.

What is YUNGJIN PHARM. CO. LTD’s market cap?

YUNGJIN PHARM. CO. LTD’s market cap is ₩229.71B.

When is YUNGJIN PHARM. CO. LTD’s upcoming earnings report date?

YUNGJIN PHARM. CO. LTD’s upcoming earnings report date is Nov 18, 2026 which is in 89 days.

How were YUNGJIN PHARM. CO. LTD’s earnings last quarter?

YUNGJIN PHARM. CO. LTD released its earnings results on Aug 14, 2026. The company reported -₩13.293 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.

Is YUNGJIN PHARM. CO. LTD overvalued?

According to Wall Street analysts YUNGJIN PHARM. CO. LTD’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does YUNGJIN PHARM. CO. LTD pay dividends?

YUNGJIN PHARM. CO. LTD does not currently pay dividends.

What is YUNGJIN PHARM. CO. LTD’s EPS estimate?

YUNGJIN PHARM. CO. LTD’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does YUNGJIN PHARM. CO. LTD have?

YUNGJIN PHARM. CO. LTD has 182,892,730 shares outstanding.

What happened to YUNGJIN PHARM. CO. LTD’s price movement after its last earnings report?

YUNGJIN PHARM. CO. LTD reported an EPS of -₩13.293 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of YUNGJIN PHARM. CO. LTD?

Currently, no hedge funds are holding shares in KR:003520

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

YUNGJIN PHARM. CO. LTD

Yungjin Pharm. Co., Ltd. engages in the development, production, and distribution of pharmaceuticals. Its products include cephalosporin, antibiotics, drugs for the central nervous system, cardiovascular, endocrine system, urinary system, respiratory, anti-inflammatory and analgesics, anti-histamine, anti-fungal, total nutrition, vitamin and supplement, cosmetics, and tonic drinks. The company was founded on July 16, 1962 and is headquartered in Seoul, South Korea.